Morgan Stanley’s Genprex GNPX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNPX
MF
MFA
VCM
FIA
CVM
SIS
Morgan Stanley's GNPX Position: Q1 2026 in Review
Morgan Stanley held its Genprex (GNPX) position steady in Q1 2026 at 0 shares worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #8206.
Morgan Stanley first reported a position in GNPX in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.13M in Q4 2021. 15 funds tracked by Wall St. Rank hold GNPX as of Q1 2026.
- Morgan Stanley held 0 shares of Genprex worth $11 as of Q1 2026.
- Morgan Stanley left its Genprex share count unchanged in Q1 2026.
- Genprex made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #8206 holding.
- Morgan Stanley first reported a position in Genprex in Q4 2020 and has held it in 15 quarters since.
- Morgan Stanley's Genprex position peaked at $1.13M in Q4 2021.
- 15 funds tracked by Wall St. Rank held Genprex as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.